The Patent Finder

Blue Engine Biologics, LLC

Also on record
Records under this name other than the patents Blue Engine Biologics, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.

Showing 1 to 10 of 10 · Back to Blue Engine Biologics, LLC

PatentTitleStatus Expires Confidence
US 8,741,282Method for treatment of tendinosis with platelet rich plasma
Lapsed on the fee record
Ended Jun 3, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jun 3, 2026From the USPTO record
US 7,462,268Particle/cell separation device and compositions
Term ended
Term ended Mar 29, 2026 · From the USPTO record
Term endedTerm ended Mar 29, 2026From the USPTO record
US 7,678,780Method of treating cancer using platelet releasate
Term ended
Term ended Jan 13, 2026 · From the USPTO record
Term endedTerm ended Jan 13, 2026From the USPTO record
US 8,088,371Compositions and minimally invasive methods for treating peripheral vascular disease
Term ended
Term ended Aug 27, 2025 · From the USPTO record
Term endedTerm ended Aug 27, 2025From the USPTO record
US 8,142,993Method of preparing neutrophil-depleted platelet-rich plasma
Term ended
Term ended Aug 16, 2025 · From the USPTO record
Term endedTerm ended Aug 16, 2025From the USPTO record
US 7,608,258Method for Treatment of Tendinosis Using Platelet Rich Plasma
Formerly held
Term ended
Ended no later than Jun 14, 2024 · Low confidence
Term endedEnded no later than Jun 14, 2024Low confidence
US 9,320,762Compositions and minimally invasive methods for treating incomplete tissue repair
Lapsed on the fee record
Ended Apr 26, 2024 · From the USPTO record
Lapsed on the fee recordEnded Apr 26, 2024From the USPTO record
US 7,314,617PRP composition and minimally invasive method for treating myocardial infarction
Term ended
Term ended Dec 20, 2023 · From the USPTO record
Term endedTerm ended Dec 20, 2023From the USPTO record
US 6,811,777Compositions and minimally invasive methods for treating incomplete connective tissue repair
Term ended
Term ended Apr 11, 2023 · From the USPTO record
Term endedTerm ended Apr 11, 2023From the USPTO record
US 8,617,539Method of administration of platelet-rich plasma to treat an acute cardiac dysfunction
Term ended
Ended no later than Apr 11, 2023 · From the USPTO record
Term endedEnded no later than Apr 11, 2023From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited